Loading...
Systemic therapy for metastatic pancreatic adenocarcinoma
Systemic treatment of metastatic pancreatic adenocarcinoma achieves only modest benefits, with evidence indicating a survival advantage with 5-fluorouracil (5-FU) over best supportive care alone, and further advantage of single-agent gemcitabine over 5-FU. There are very few regimens better than sin...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126009/ https://ncbi.nlm.nih.gov/pubmed/21789129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009357188 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|